HomeLatest ThreadsGreatest ThreadsForums & GroupsMy SubscriptionsMy Posts
DU Home » Latest Threads » Forums & Groups » Main » General Discussion (Forum) » Hamilton researchers have...

Fri Jun 11, 2021, 11:33 AM

Hamilton researchers have recommended treatment for rare blood clotting

From Global News Canada


"Researchers at McMaster University are recommending a pair of treatments to fight Vaccine-induced thrombotic thrombocytopenia (VITT), identified in a small number of COVID-19 vaccine recipients.

A group from the McMaster Platelet Immunology Laboratory (MPIL), building off of previous investigations into a condition that prevents blood clotting, are suggesting that a combination of anti-clotting drugs with high doses of intravenous immunoglobulin an antibody solution may be effective against VITT.

VITT has been associated with but not definitively linked to the viral vector shots from Oxford-AstraZeneca and Johnson & Johnson."


For AstraZeneca first-dose recipients like myself, the risk of a clot with a second shot is orders of magnitude less than the first (which is why Canada is now only giving Astrazeneca as second doses to those who had AstraZeneca as their first, and why I'm not worried about getting my second shot of AZ).

That said, still good news - and may be applicable to clots caused by the J&J as well.

0 replies, 409 views

Reply to this thread

Back to top Alert abuse

Reply to this thread